Evolve BioSystems Secures $9,000,000 Series A Funding Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=0abed471-dad3-427f-bd2b-d0eebeedd4f8
Date
8/19/2015
Company Name
Evolve BioSystems
Mailing Address
3354 Laguna Street San Francisco, CA 94123 USA
Company Description
Evolve Biosystems will develop and bring to market the next generation of probiotic-based biotherapeutics to establish, restore, and maintain a healthy human microbiome across a range of unmet clinical needs.
Website
http://www.evolvebiosystems.com
Transaction Type
Venture Equity
Transaction Amount
$9,000,000
Transaction Round
Series A
Proceeds Purposes
This investment is timely, as it will accelerate our efforts to move these new discoveries into commercial products that can improve the health outcomes for infants globally.
M&A Terms
Venture Investor
Horizons Ventures
Venture Investor
Undisclosed